🔓 Unlock the full profile of Ben Zeskind (Immuneering Corporation), including verified contact details, financial insights, and professional associations.
See Ben Zeskind Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: ben*****@imm******.com
Mobile: 92102*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Ben Zeskind is the Co-Founder and CEO of Immuneering Corporation, a company founded in 2008, located in New York, New York.
- Immuneering Corporation focuses on developing innovative therapies for cancer and other diseases, utilizing advanced computational biology to guide drug discovery and development.
- Under Zeskind's leadership, Immuneering has positioned itself as a forward-thinking player in the biotech industry, actively trading on NASDAQ with the ticker symbol IMRX.
- The company has demonstrated steady market growth, with a reported market capitalization of 42.8 million and a twelve-month headcount growth of approximately 1.6%.
- Prior to founding Immuneering, Zeskind worked in business development and new product planning at Merck, where strategic insights were gained in pharmaceutical advancements.
- Zeskind also contributed to the scientific community as a graduate student and postdoc at the Whitehead Institute for Biomedical Research, focusing on innovative research in the biomedical field.
- Immuneering has been recognized for its novel therapeutic approaches, with a strong emphasis on collaboration and partnership in the research community.
- The combination of Zeskind's scientific and business acumen has been pivotal in navigating the challenges of the biotech landscape, ensuring the corporation's resilience and adaptability.
- Immuneering maintains an active online presence through its official website and social media, fostering communication and engagement with stakeholders.